The invention relates to novel cyclic peptide derivatives of general formula (I): ##STR00001## wherein A, B, R.sup.1 and R.sup.2 are as defined in the specification, pharmaceutically acceptable salts thereof, and their use as pharmaceuticals, in particular for the treatment of hepatitis C virus.